Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705015200 on October 26, 2007

J. Biol. Chem., Vol. 282, Issue 51, 37064-37073, December 21, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/51/37064    most recent
M705015200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Y. V.
Right arrow Articles by Semenza, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y. V.
Right arrow Articles by Semenza, G. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calcineurin Promotes Hypoxia-inducible Factor 1{alpha} Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization*

Ye V. Liu{ddagger}§1, Maimon E. Hubbi{ddagger}, Fan Pan||, Karin R. McDonald{ddagger}§, Malini Mansharamani**, Robert N. Cole**, Jun O. Liu||, and Gregg L. Semenza{ddagger}§{ddagger}{ddagger}2

From the {ddagger}Vascular Program, Institute for Cell Engineering, §McKusick-Nathans Institute of Genetic Medicine, Graduate Training Program in Cellular and Molecular Medicine, the ||Department of Pharmacology and Molecular Sciences, the **Mass Spectrometry/Proteomics Facility, Department of Biological Chemistry, and the {ddagger}{ddagger}Departments of Pediatrics, Medicine, Oncology, and Radiation Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Oxygen homeostasis represents an essential organizing principle of metazoan evolution and biology. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of transcriptional responses to changes in O2 concentration. HIF-1 is a heterodimer of HIF-1{alpha} and HIF-1β subunits. O2-dependent degradation of the HIF-1{alpha} subunit is mediated by prolyl hydroxylase, von Hippel-Lindau protein (VHL)/Elongin-C E3 ubiquitin ligase, and the proteasome. O2-independent degradation of HIF-1{alpha} is regulated by the competition of RACK1 and HSP90 for binding to HIF-1{alpha}. RACK1 binding results in the recruitment of the Elongin-C E3 ubiquitin ligase, leading to VHL-independent ubiquitination and degradation of HIF-1{alpha}. In this report, we show that calcineurin inhibits the ubiquitination and proteasomal degradation of HIF-1{alpha}. Calcineurin is a serine/threonine phosphatase that is activated by calcium and calmodulin. The phosphatase activity of calcineurin is required for its regulation of HIF-1{alpha}. RACK1 binds to the catalytic domain of calcineurin and is required for HIF-1{alpha} degradation induced by the calcineurin inhibitor cyclosporine A. Elongin-C and HIF-1{alpha} each bind to RACK1 and dimerization of RACK1 is required to recruit Elongin-C to HIF-1{alpha}. Phosphorylation of RACK1 promotes its dimerization and dephosphorylation by calcineurin inhibits dimerization. Serine 146 within the dimerization domain is phosphorylated and mutation of serine 146 impairs RACK1 dimerization and HIF-1{alpha} degradation. These results indicate that intracellular calcium levels can regulate HIF-1{alpha} expression by modulating calcineurin activity and RACK1 dimerization.


Received for publication, June 18, 2007 , and in revised form, October 4, 2007.

* This work was supported by National Institutes of Health NHLBI Grant N01-HV28180. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: Novavax, Inc., 9920 Belward Campus Dr., Rockville, MD 20850.

2 To whom correspondence should be addressed: Broadway Research Bldg., Suite 671, 733 N. Broadway, Baltimore, MD 21205. Fax: 443-287-5618; E-mail: gsemenza{at}jhmi.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Wagner, C. Jehl-Pietri, P. Lopez, J. Murdaca, C. Giordano, C. Schwartz, P. Gounon, S. N. Hatem, P. Grimaldi, and K.-D. Wagner
Peroxisome proliferator-activated receptor {beta} stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin
Cardiovasc Res, July 1, 2009; 83(1): 61 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Singh, S. M. Manda, D. Sikder, M. J. Birrer, B. A. Rothermel, D. J. Garry, and P. P. A. Mammen
Calcineurin Activates Cytoglobin Transcription in Hypoxic Myocytes
J. Biol. Chem., April 17, 2009; 284(16): 10409 - 10421.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
G. L. Semenza
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Physiology, April 1, 2009; 24(2): 97 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Kiely, G. S. Baillie, M. J. Lynch, M. D. Houslay, and R. O'Connor
Tyrosine 302 in RACK1 Is Essential for Insulin-like Growth Factor-I-mediated Competitive Binding of PP2A and {beta}1 Integrin and for Tumor Cell Proliferation and Migration
J. Biol. Chem., August 22, 2008; 283(34): 22952 - 22961.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Basu, A. G. Contreras, D. Datta, E. Flynn, L. Zeng, H. T. Cohen, D. M. Briscoe, and S. Pal
Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
Cancer Res., July 15, 2008; 68(14): 5689 - 5698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement